An anonymous director reports

CIPHER PHARMACEUTICALS SCHEDULES Q4 2023 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the fourth quarter and full year of 2023 after the market close on Thursday, March 14, 2024. The company will also hold a conference call on Friday, March 15, at 8:30 a.m. ET to discuss the results and corporate developments.

Conference call details

Date: March 15, 2024

Time: 8:30 a.m.

Dial-in number: 416-764-8650 or 888-664-6383

Replay: 416-764-8677 or 888-390-0541

Code: 128854 followed by pound key

Expires: March 22, 2024

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early-stage to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America.